Moreover, Alpinumisoflavone and Cordycepin are two drugs with NRF2-dependent radiosensitizing properties in esophageal squamous cell carcinoma and breast cancer, respectively (177, 184). The gene discussed is NFE2L2; the disease is esophageal squamous cell carcinoma.